食品伙伴网讯    据欧盟食品安全局（EFSA）消息，应欧盟委员会的要求，欧盟食品安全局就人工合成的反式白藜芦醇（trans-resveratrol）作为新型食品的安全性发布意见。

    申请人拟将这种新型食品作为食品补充剂用于胶囊或片剂，每日用量为150毫克/天。欧盟专家组经过评估认为，代谢物反式白藜芦醇硫酸盐可以阻碍人体CYP酶，并且可能与CYP2C9代谢后的药物起反应。最后认为，按照规定条件使用反式白藜芦醇是安全的。

    部分原文报道如下：

    Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked for an opinion on the safety of synthetic trans-resveratrol as a novel food with a purity of ≥99% （w/w）。 The Panel considers that the information provided on the composition and specifications of the novel food is sufficient. The applicant intends to market the novel food as a food supplement in capsule or tablet form at daily doses up to 150 mg/day.

    原文链接：<http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/4368.pdf>